Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.4600 (0.22%) ($38.2250 - $38.4600) on Wed. Sep. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.12% (three month average) | RSI | 48 | Latest Price | $38.4600(0.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.6% a day on average for past five trading days. | Weekly Trend | HALO declines -0.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(61%) PEJ(49%) TIP(37%) ACES(11%) VT(20%) | Factors Impacting HALO price | HALO will decline at least -1.06% in a week (0% probabilities). IDRV(-57%) IFRA(24%) ICLN(40%) IWD(14%) IWN(34%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.06% (StdDev 2.12%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $32.48(-15.55%) | Resistance Level | $39.87 | 5 Day Moving Average | $39.06(-1.54%) | 10 Day Moving Average | $39.31(-2.16%) | 20 Day Moving Average | $39.87(-3.54%) | To recent high | -12.7% | To recent low | 12.5% | Market Cap | $5.256b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |